116 related articles for article (PubMed ID: 19101153)
1. Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
Zhang X; Qiu Y; Li X; Bhattacharjee S; Woods M; Kraft P; Lundeen SG; Sui Z
Bioorg Med Chem; 2009 Jan; 17(2):855-66. PubMed ID: 19101153
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions.
Carroll WA; Altenbach RJ; Bai H; Brioni JD; Brune ME; Buckner SA; Cassidy C; Chen Y; Coghlan MJ; Daza AV; Drizin I; Fey TA; Fitzgerald M; Gopalakrishnan M; Gregg RJ; Henry RF; Holladay MW; King LL; Kort ME; Kym PR; Milicic I; Tang R; Turner SC; Whiteaker KL; Yi L; Zhang H; Sullivan JP
J Med Chem; 2004 Jun; 47(12):3163-79. PubMed ID: 15163196
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro.
Carroll WA; Agrios KA; Altenbach RJ; Buckner SA; Chen Y; Coghlan MJ; Daza AV; Drizin I; Gopalakrishnan M; Henry RF; Kort ME; Kym PR; Milicic I; Smith JC; Tang R; Turner SC; Whiteaker KL; Zhang H; Sullivan JP
J Med Chem; 2004 Jun; 47(12):3180-92. PubMed ID: 15163197
[TBL] [Abstract][Full Text] [Related]
5. N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region.
Ohnmacht CJ; Russell K; Empfield JR; Frank CA; Gibson KH; Mayhugh DR; McLaren FM; Shapiro HS; Brown FJ; Trainor DA; Ceccarelli C; Lin MM; Masek BB; Forst JM; Harris RJ; Hulsizer JM; Lewis JJ; Silverman SM; Smith RW; Warwick PJ; Kau ST; Chun AL; Grant TL; Howe BB; Neilson KL
J Med Chem; 1996 Nov; 39(23):4592-601. PubMed ID: 8917648
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
Perez-Medrano A; Brune ME; Buckner SA; Coghlan MJ; Fey TA; Gopalakrishnan M; Gregg RJ; Kort ME; Scott VE; Sullivan JP; Whiteaker KL; Carroll WA
J Med Chem; 2007 Nov; 50(24):6265-73. PubMed ID: 17973362
[TBL] [Abstract][Full Text] [Related]
7. Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
Altenbach RJ; Brune ME; Buckner SA; Coghlan MJ; Daza AV; Fabiyi A; Gopalakrishnan M; Henry RF; Khilevich A; Kort ME; Milicic I; Scott VE; Smith JC; Whiteaker KL; Carroll WA
J Med Chem; 2006 Nov; 49(23):6869-87. PubMed ID: 17154517
[TBL] [Abstract][Full Text] [Related]
8. Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portion.
Atwal KS; Ferrara FN; Ding CZ; Grover GJ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
J Med Chem; 1996 Jan; 39(1):304-13. PubMed ID: 8568821
[TBL] [Abstract][Full Text] [Related]
9. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M
J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752
[TBL] [Abstract][Full Text] [Related]
10. Spirocyclic benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel.
Breschi MC; Calderone V; Digiacomo M; Manganaro M; Martelli A; Minutolo F; Rapposelli S; Testai L; Tonelli F; Balsamo A
J Med Chem; 2008 Nov; 51(21):6945-54. PubMed ID: 18925735
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and vasorelaxant activities of benzopyran-4-one hydrazone derivatives].
Zhao SY; Huang WL; Zhang HB
Yao Xue Xue Bao; 2002 Aug; 37(8):621-5. PubMed ID: 12567776
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of a novel class of naphthyl amide KATP channel openers.
Turner SC; Carroll WA; White TK; Brune ME; Buckner SA; Gopalakrishnan M; Fabiyi A; Coghlan MJ; Scott VE; Castle NA; Daza AV; Milicic I; Sullivan JP
Bioorg Med Chem Lett; 2003 May; 13(10):1741-4. PubMed ID: 12729655
[TBL] [Abstract][Full Text] [Related]
13. Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel.
Calderone V; Testai L; Martelli A; Rapposelli S; Digiacomo M; Balsamo A; Breschi MC
Biochem Pharmacol; 2010 Jan; 79(1):39-47. PubMed ID: 19660436
[TBL] [Abstract][Full Text] [Related]
14. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
[TBL] [Abstract][Full Text] [Related]
15. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
Tyrrell E; Tesfa KH; Greenwood I; Mann A
Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
[TBL] [Abstract][Full Text] [Related]
16. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenediones.
Gilbert AM; Antane MM; Argentieri TM; Butera JA; Francisco GD; Freeden C; Gundersen EG; Graceffa RF; Herbst D; Hirth BH; Lennox JR; McFarlane G; Norton NW; Quagliato D; Sheldon JH; Warga D; Wojdan A; Woods M
J Med Chem; 2000 Mar; 43(6):1203-14. PubMed ID: 10737753
[TBL] [Abstract][Full Text] [Related]
17. New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic properties.
Breschi MC; Calderone V; Martelli A; Minutolo F; Rapposelli S; Testai L; Tonelli F; Balsamo A
J Med Chem; 2006 Dec; 49(26):7600-2. PubMed ID: 17181142
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-diones.
Butera JA; Jenkins DJ; Lennox JR; Sheldon JH; Norton NW; Warga D; Argentieri TM
Bioorg Med Chem Lett; 2005 May; 15(10):2495-501. PubMed ID: 15863304
[TBL] [Abstract][Full Text] [Related]
19. Bladder-relaxant properties of the novel benzofuroindole analogue LDD175.
dela Peña IC; Yoon SY; Kim SM; Lee GS; Ryu JH; Park CS; Kim YC; Cheong JH
Pharmacology; 2009; 83(6):367-78. PubMed ID: 19451752
[TBL] [Abstract][Full Text] [Related]
20. Second-generation K(ATP) channel openers.
Mannhold R; Leclerc G
Mini Rev Med Chem; 2005 Nov; 5(11):961-9. PubMed ID: 16307527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
